Kiniksa Pharmaceuticals

KNSA

Market cap $3B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$52

31% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wedbush David Nierengarten 67% 1-yr KNSA win rate				13 Jan ‘26 2 days ago
Goldman Sachs Paul Choi 100% 1-yr KNSA win rate				29 Oct ‘25 2 months ago
Citigroup Geoff Meacham 100% 1-yr KNSA win rate				17 Oct ‘25 2 months ago